Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo

Key Points

• 3D imaging offers an objective way to assess changes in facial vitiligo after treatment.
• The trial indicates potential benefits from upadacitinib for patients with this skin condition.
• Randomized controlled trial methods were applied to ensure reliable results with treatment evaluation.
• Results suggest that using 3D imaging could refine monitoring in vitiligo therapies.